prompt stringclasses 1
value | id stringlengths 11 11 | instruction stringlengths 710 15.1k | output stringlengths 47 105 | Train int64 0 0 |
|---|---|---|---|---|
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03912415 | {'Official Title': 'An International Randomized Double-blind Clinical Trial of BCD-100 Plus Platinum-based Chemotherapy With and Without Bevacizumab Versus Placebo Plus Platinum-based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer\n', 'Brief Summary': 'This i... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03912415 | {'Official Title': 'An International Randomized Double-blind Clinical Trial of BCD-100 Plus Platinum-based Chemotherapy With and Without Bevacizumab Versus Placebo Plus Platinum-based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer\n', 'Brief Summary': 'This i... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04526470 | {'Official Title': 'Phase IB/II Study of Alpelisib in Combination With Paclitaxel in Patients With PIK3CA-altered Metastatic/Recurrent Gastric Cancer', 'Brief Summary': 'Alpelisib (BYL719) is a PIK3CA-specific inhibitor, which was developed by Novartis (Basel, Switzerland). Our group conducted pre-clinical study of alp... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03909334 | {'Official Title': 'An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC', 'Brief Summary': 'The primary objective of the study is to evaluate the efficac... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03909334 | {'Official Title': 'An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC', 'Brief Summary': 'The primary objective of the study is to evaluate the efficac... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04686305 | {'Official Title': 'A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human E... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04686305 | {'Official Title': 'A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human E... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04686305 | {'Official Title': 'A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human E... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04686305 | {'Official Title': 'A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human E... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04686305 | {'Official Title': 'A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human E... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04686305 | {'Official Title': 'A Phase Ib Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan (T-DXd) and Immunotherapy Agents With and Without Chemotherapy Agents in First-line Treatment of Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) and Human E... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02555189 | {'Official Title': 'Randomized Phase IB/II Study of Enzalutamide With and Without Ribociclib in Patients With Metastatic Castrate Resistant, Chemotherapy Naïve Prostate Cancer That Retains RB Expression\n', 'Brief Summary': 'This partially randomized phase IB/II trial studies the side effects and best dose of ribocicli... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02555189 | {'Official Title': 'Randomized Phase IB/II Study of Enzalutamide With and Without Ribociclib in Patients With Metastatic Castrate Resistant, Chemotherapy Naïve Prostate Cancer That Retains RB Expression\n', 'Brief Summary': 'This partially randomized phase IB/II trial studies the side effects and best dose of ribocicli... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03647969 | {'Official Title': 'Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction - A Randomized Phase 2 Trial.', 'Brief Summary': 'Patients with Her2 negative, previously untreated meta... | {'Arm - Disease - Stage of Cancer': 'Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03647969 | {'Official Title': 'Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction - A Randomized Phase 2 Trial.', 'Brief Summary': 'Patients with Her2 negative, previously untreated meta... | {'Arm - Disease - Stage of Cancer': 'Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03647969 | {'Official Title': 'Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction - A Randomized Phase 2 Trial.', 'Brief Summary': 'Patients with Her2 negative, previously untreated meta... | {'Arm - Disease - Stage of Cancer': 'Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03647969 | {'Official Title': 'Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction - A Randomized Phase 2 Trial.', 'Brief Summary': 'Patients with Her2 negative, previously untreated meta... | {'Arm - Disease - Stage of Cancer': 'Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02824458 | {'Official Title': 'A Multicenter, Randomized,Double-Blind Study of Gefitinib in Combination With Apatinib or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Advanced Non-squamous Non-Small-Cell Lung Cancer', 'Brief Summary': 'The main purpose of this study is to evaluate the safety and efficacy of... | {'Arm - Disease - Stage of Cancer': 'Stage ⅢB-IV , Advanced, locally advanced, metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02824458 | {'Official Title': 'A Multicenter, Randomized,Double-Blind Study of Gefitinib in Combination With Apatinib or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Advanced Non-squamous Non-Small-Cell Lung Cancer', 'Brief Summary': 'The main purpose of this study is to evaluate the safety and efficacy of... | {'Arm - Disease - Stage of Cancer': 'Stage ⅢB-IV , Advanced, locally advanced, metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05214222 | {'Official Title': 'Penpulimab Plus Chemotherapy With or Without Anlotinib as First-line Therapy for Patients With Advanced Esophageal Squamous Cell Carcinoma (Answer): A Randomized Two-arm Clinical Study', 'Brief Summary': 'Penpulimab plus chemotherapy with or without Anlotinib as first-line therapy for patients with ... | {'Arm - Disease - Stage of Cancer': 'advanced, metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05214222 | {'Official Title': 'Penpulimab Plus Chemotherapy With or Without Anlotinib as First-line Therapy for Patients With Advanced Esophageal Squamous Cell Carcinoma (Answer): A Randomized Two-arm Clinical Study', 'Brief Summary': 'Penpulimab plus chemotherapy with or without Anlotinib as first-line therapy for patients with ... | {'Arm - Disease - Stage of Cancer': 'advanced, metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05842317 | {'Official Title': 'A Randomized, Controlled, Single-center Clinical Study of Lenvatinib in Combination With Tislelizumab With or Without TACE in First-line Treatment of Advanced Hepatocellular Carcinoma.', 'Brief Summary': 'To explore the effects of lenvatinib in combination with tislelizumab with or without TACE in p... | {'Arm - Disease - Stage of Cancer': 'Advanced '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05842317 | {'Official Title': 'A Randomized, Controlled, Single-center Clinical Study of Lenvatinib in Combination With Tislelizumab With or Without TACE in First-line Treatment of Advanced Hepatocellular Carcinoma.', 'Brief Summary': 'To explore the effects of lenvatinib in combination with tislelizumab with or without TACE in p... | {'Arm - Disease - Stage of Cancer': 'Advanced '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05163249 | {'Official Title': 'A Prospective, Pilot Study of First-line Osimertinib With or Without Savolitinib in de Novo MET Positive, EGFR-mutant NSCLCs (FLOWERS)\n', 'Brief Summary': 'This is a prospective, pilot, two-arm, randomized, multicenter study exploring the efficacy and safety of osimertinib with or without savolitin... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05163249 | {'Official Title': 'A Prospective, Pilot Study of First-line Osimertinib With or Without Savolitinib in de Novo MET Positive, EGFR-mutant NSCLCs (FLOWERS)\n', 'Brief Summary': 'This is a prospective, pilot, two-arm, randomized, multicenter study exploring the efficacy and safety of osimertinib with or without savolitin... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03675737 | {'Official Title': 'A Phase 3, Randomized, Double-blind Clinical Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-line Treatment in Participants With HER2 Negative, Previously Untreated, Unresectable or Metastatic Gastric Orgastroesophageal Junction Adenocarcinoma (KEYNOTE-85... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03675737 | {'Official Title': 'A Phase 3, Randomized, Double-blind Clinical Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-line Treatment in Participants With HER2 Negative, Previously Untreated, Unresectable or Metastatic Gastric Orgastroesophageal Junction Adenocarcinoma (KEYNOTE-85... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04308785 | {'Official Title': 'A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 2 Study to Investigate the Efficacy and Safety of Atezolizumab With or Without Tiragolumab as Consolidation Therapy in Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed After Chemoradiotherapy\n', 'Brief Summ... | {'Arm - Disease - Stage of Cancer': 'Limited Stage '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04308785 | {'Official Title': 'A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 2 Study to Investigate the Efficacy and Safety of Atezolizumab With or Without Tiragolumab as Consolidation Therapy in Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed After Chemoradiotherapy\n', 'Brief Summ... | {'Arm - Disease - Stage of Cancer': 'Limited Stage '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03504397 | {'Official Title': 'A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab (IMAB362) Plus mFOLFOX6 Compared With Placebo Plus mFOLFOX6 as First-line Treatment of Subjects With Claudin (CLDN)18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesop... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03504397 | {'Official Title': 'A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab (IMAB362) Plus mFOLFOX6 Compared With Placebo Plus mFOLFOX6 as First-line Treatment of Subjects With Claudin (CLDN)18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesop... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04543617 | {'Official Title': 'A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab With or Without Tiragolumab (Anti-TIGIT Antibody) in Patients With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy\n', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Non-Progressive Following Definitive Concurrent Chemoradiotherapy '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04543617 | {'Official Title': 'A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab With or Without Tiragolumab (Anti-TIGIT Antibody) in Patients With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy\n', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Non-Progressive Following Definitive Concurrent Chemoradiotherapy '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04543617 | {'Official Title': 'A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab With or Without Tiragolumab (Anti-TIGIT Antibody) in Patients With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy\n', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Non-Progressive Following Definitive Concurrent Chemoradiotherapy '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04340193 | {'Official Title': 'A Randomized, Multi-center, Double-blinded, Placebo-controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination With Trans-arterial ChemoEmbolization (TACE) in Patients With Intermediate-stage Hepatocellular Carcinoma (HCC)', 'Brief Summary': 'The purpose o... | {'Arm - Disease - Stage of Cancer': 'Intermediate-stage'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04340193 | {'Official Title': 'A Randomized, Multi-center, Double-blinded, Placebo-controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination With Trans-arterial ChemoEmbolization (TACE) in Patients With Intermediate-stage Hepatocellular Carcinoma (HCC)', 'Brief Summary': 'The purpose o... | {'Arm - Disease - Stage of Cancer': 'Intermediate-stage'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04340193 | {'Official Title': 'A Randomized, Multi-center, Double-blinded, Placebo-controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination With Trans-arterial ChemoEmbolization (TACE) in Patients With Intermediate-stage Hepatocellular Carcinoma (HCC)', 'Brief Summary': 'The purpose o... | {'Arm - Disease - Stage of Cancer': 'Intermediate-stage'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05904886 | {'Official Title': 'A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma\n', 'Brief Summary': 'The purpose of this study is to assess the efficacy and safet... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05904886 | {'Official Title': 'A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma\n', 'Brief Summary': 'The purpose of this study is to assess the efficacy and safet... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03592472 | {'Official Title': 'A Randomized, Phase 3, Double-blind, Placebo-controlled Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma(RENAVIV)\n', 'Brief Summary': 'This is a randomized, Phase 3, double-blind, placebo-controlled study of pazopanib plus abexinost... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03592472 | {'Official Title': 'A Randomized, Phase 3, Double-blind, Placebo-controlled Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma(RENAVIV)\n', 'Brief Summary': 'This is a randomized, Phase 3, double-blind, placebo-controlled study of pazopanib plus abexinost... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04199104 | {'Official Title': 'A Phase 3, Randomized, Placebo-controlled, Double-blind Clinical Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) to Evaluate the Safety and Efficacy of Pembrolizumab and Lenvatinib as 1L Intervention in a PD-L1 Selected Population of Participants With Recurrent or Metasta... | {'Arm - Disease - Stage of Cancer': 'M1/Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04199104 | {'Official Title': 'A Phase 3, Randomized, Placebo-controlled, Double-blind Clinical Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) to Evaluate the Safety and Efficacy of Pembrolizumab and Lenvatinib as 1L Intervention in a PD-L1 Selected Population of Participants With Recurrent or Metasta... | {'Arm - Disease - Stage of Cancer': 'M1/Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05523323 | {'Official Title': 'A Phase 3, Randomized, Placebo-controlled, Double-blind Clinical Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) to Evaluate the Safety and Efficacy of Pembrolizumab and Lenvatinib as 1L Intervention in a PD-L1 Selected Population of Participants With Recurrent or Metasta... | {'Arm - Disease - Stage of Cancer': 'Metastatic, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05523323 | {'Official Title': 'A Phase 3, Randomized, Placebo-controlled, Double-blind Clinical Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) to Evaluate the Safety and Efficacy of Pembrolizumab and Lenvatinib as 1L Intervention in a PD-L1 Selected Population of Participants With Recurrent or Metasta... | {'Arm - Disease - Stage of Cancer': 'Metastatic, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04571489 | {'Official Title': 'Gimatecan (ST1481) as Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer: an Open-label, Randomized, Controlled Phase II Study', 'Brief Summary': 'This phase II clinical trial studies the safety and effect of as second-line treatmen in local advanced or metastatic pancreatic ... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04571489 | {'Official Title': 'Gimatecan (ST1481) as Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer: an Open-label, Randomized, Controlled Phase II Study', 'Brief Summary': 'This phase II clinical trial studies the safety and effect of as second-line treatmen in local advanced or metastatic pancreatic ... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04204941 | {'Official Title': 'A Phase 1b/3 Global, Randomized, Double-blind, Placebo-Controlled Trial of Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma\n', 'Brief Summary': 'The participants of this study will have advanced epithelioid sarcoma. Sarcoma is a cancer of the connec... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04204941 | {'Official Title': 'A Phase 1b/3 Global, Randomized, Double-blind, Placebo-Controlled Trial of Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma\n', 'Brief Summary': 'The participants of this study will have advanced epithelioid sarcoma. Sarcoma is a cancer of the connec... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03092856 | {'Official Title': 'Phase II Randomized Double Blind Trial of PF-04518600, an OX40 Antibody, in Combination With Axitinib Versus Axitinib in Immune-Checkpoint Inhibitor Exposed Patients With Metastatic Renal Cell Carcinoma', 'Brief Summary': 'This randomized phase II trial studies how well axitinib with or without anti... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03092856 | {'Official Title': 'Phase II Randomized Double Blind Trial of PF-04518600, an OX40 Antibody, in Combination With Axitinib Versus Axitinib in Immune-Checkpoint Inhibitor Exposed Patients With Metastatic Renal Cell Carcinoma', 'Brief Summary': 'This randomized phase II trial studies how well axitinib with or without anti... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01927744 | {'Official Title': 'Randomized, Placebo-Controlled, Phase 2 Study Of Induction Chemotherapy With Cisplatin/Carboplatin, And Docetaxel With Or Without Erlotinib In Patients With Head And Neck Squamous Cell Carcinomas Amenable For Surgical Resection\n', 'Brief Summary': 'The goal of this clinical research study is to lea... | {'Arm - Disease - Stage of Cancer': 'Stage III, IVA or IVB'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01927744 | {'Official Title': 'Randomized, Placebo-Controlled, Phase 2 Study Of Induction Chemotherapy With Cisplatin/Carboplatin, And Docetaxel With Or Without Erlotinib In Patients With Head And Neck Squamous Cell Carcinomas Amenable For Surgical Resection\n', 'Brief Summary': 'The goal of this clinical research study is to lea... | {'Arm - Disease - Stage of Cancer': 'Stage III, IVA or IVB'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04194203 | {'Official Title': 'A Phase III, Randomized, Double-Blind Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)\n', 'Brief Summary': "This study will evaluate the efficacy and safety ... | {'Arm - Disease - Stage of Cancer': 'Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04194203 | {'Official Title': 'A Phase III, Randomized, Double-Blind Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)\n', 'Brief Summary': "This study will evaluate the efficacy and safety ... | {'Arm - Disease - Stage of Cancer': 'Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04674956 | {'Official Title': 'A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine Versus Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic ... | {'Arm - Disease - Stage of Cancer': 'Metastatic, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04674956 | {'Official Title': 'A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine Versus Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic ... | {'Arm - Disease - Stage of Cancer': 'Metastatic, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05640830 | {'Official Title': 'A Phase 1B/2 Study of Trastuzumab, Bevacizumab With Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy (TREAZURE)\n', 'Brief Summary': 'This is a multicenter, open-label, prospective, phase 2 study of trastuzumab, bevacizumab, and paclitaxel as second-line treatment for patients wi... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05121350 | {'Official Title': 'A Multicenter, Randomized, Double-blind, Parallel-controlled Phase III Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma\n', ... | {'Arm - Disease - Stage of Cancer': 'Advanced '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05121350 | {'Official Title': 'A Multicenter, Randomized, Double-blind, Parallel-controlled Phase III Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma\n', ... | {'Arm - Disease - Stage of Cancer': 'Advanced '} | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.